A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry

Ebola virus (EBOV) causes highly lethal disease outbreaks against which no FDA-approved countermeasures are available. Although many host factors exploited by EBOV for cell entry have been identified, including host cell surface phosphatidylserine receptors, endosomal cysteine proteases, and the lys...

Descripción completa

Detalles Bibliográficos
Autores principales: Fels, J. Maximilian, Spence, Jennifer S., Bortz, Robert H., Bornholdt, Zachary A., Chandran, Kartik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747718/
https://www.ncbi.nlm.nih.gov/pubmed/31289183
http://dx.doi.org/10.1128/mBio.01408-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747718/
https://www.ncbi.nlm.nih.gov/pubmed/31289183
http://dx.doi.org/10.1128/mBio.01408-19

Ejemplares similares